sec filing
FA
NASDAQ · FATE
Fate Therapeutics, Inc.
Healthcare · Biotechnology
$2.33
Down-$0.02 (-0.64%)
Updated Sep 11, 2026, 4:07 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128M
- P/E ratio
- -0.85
- Dividend yield
- 0.00%
- 52-week range
- $0.94 – $3.23
- Volume
- 751.11K
- Avg. volume
- 2.11M
Price performance
FATE price history
1M range · 20 trading sessions · Daily adjusted prices
FATE closed at $2.33 after 20 trading sessions, down 7.54% for the selected period.
- Last close
- $2.33
- Period change
- -7.54%
- Period low
- $2.33
- Period high
- $2.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $2.42 | $2.45 | $2.28 | $2.33 | 751.11K |
| Sep 9, 2026 | $2.48 | $2.52 | $2.4243 | $2.44 | 553.58K |
| Sep 8, 2026 | $2.45 | $2.55 | $2.395 | $2.50 | 1.92M |
| Sep 4, 2026 | $2.38 | $2.49 | $2.38 | $2.48 | 611.43K |
| Sep 3, 2026 | $2.45 | $2.505 | $2.40 | $2.42 | 715.44K |
| Sep 2, 2026 | $2.43 | $2.505 | $2.38 | $2.45 | 1.22M |
| Sep 1, 2026 | $2.35 | $2.48 | $2.335 | $2.43 | 1.04M |
| Aug 31, 2026 | $2.40 | $2.435 | $2.365 | $2.39 | 549.27K |
| Aug 28, 2026 | $2.51 | $2.53 | $2.41 | $2.43 | 714.9K |
| Aug 27, 2026 | $2.56 | $2.595 | $2.505 | $2.54 | 1.57M |
| Aug 26, 2026 | $2.54 | $2.60 | $2.50 | $2.57 | 1.05M |
| Aug 25, 2026 | $2.46 | $2.62 | $2.455 | $2.55 | 2.44M |
| Aug 24, 2026 | $2.34 | $2.45 | $2.23 | $2.44 | 1.31M |
| Aug 21, 2026 | $2.46 | $2.508 | $2.32 | $2.33 | 1.7M |
| Aug 20, 2026 | $2.65 | $2.65 | $2.44 | $2.45 | 1.57M |
| Aug 19, 2026 | $2.61 | $2.70 | $2.59 | $2.65 | 1.22M |
| Aug 18, 2026 | $2.59 | $2.63 | $2.534 | $2.56 | 942.75K |
| Aug 17, 2026 | $2.57 | $2.70 | $2.51 | $2.62 | 3.18M |
| Aug 14, 2026 | $2.58 | $2.60 | $2.48 | $2.57 | 2M |
| Aug 13, 2026 | $2.83 | $2.85 | $2.51 | $2.52 | 2.37M |
Latest FATE news
The latest Smart Investors Daily articles mentioning FATE.
Stock researchResearch & News · SID Coverage
Loading stock research…